Characterization of Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B as in Vitro Substrates for Farnesyl Protein Transferase and Geranylgeranyl Protein Transferase Type I
Open accessAbstract
Ras proteins are small GTP-binding proteins which are critical for cell signaling and proliferation. Four Ras isoforms exist: Ha-Ras, N-Ras, Ki-Ras4A, and Ki-Ras4B. The carboxyl termini of all four isoforms are post-translationally modified by farnesyl protein transferase (FPT). Prenylation is required for oncogenic Ras to transform cells. Recently, it was reported that Ki-Ras4B is also an in vitro substrate for the related enzyme geranylgeranyl protein transferase-1 (GGPT-1) (James, G. L., Goldstein, J. L., and Brown, M. S. (1995) J. Biol. Chem. 270, 6221-6226). In the current studies, we compared the four isoforms of Ras as substrates for FPT and GGPT-1. The affinity of FPT for Ki-Ras4B (Km = 30 nM) is 10-20-fold higher than that for the other Ras isoforms. Consistent with this, when the different Ras isoforms are tested at equimolar concentrations, it requires 10-20-fold higher levels of CAAX-competitive compounds to inhibit Ki-Ras4B farnesylation. Additionally, we found that, as reported for Ki-Ras4B, N-Ras and Ki-Ras4A are also in vitro substrates for GGPT-1. Of the Ras isoforms, N-Ras is the highest affinity substrate for GGPT-1 and is similar in affinity to a standard GGPT-1 substrate terminating in leucine. However, the catalytic efficiencies of these geranylgeranylation reactions are between 15- and 140-fold lower than the corresponding farnesylation reactions, largely reflecting differences in affinity. Carboxyl-terminal peptides account for many of the properties of the Ras proteins. One interesting exception is that, unlike the full-length N-Ras protein, a carboxyl-terminal N-Ras peptide is not a GGPT-1 substrate, raising the possibility that upstream sequences in this protein may play a role in its recognition by GGPT-1. Studies with various carboxyl-terminal peptides from Ki-Ras4B suggest that both the carboxyl-terminal methionine and the upstream polylysine region are important determinants for geranylgeranylation. Furthermore, it was found that full-length Ki-Ras4B, but not other Ras isoforms, can be geranylgeranylated in vitro by FPT. These findings suggest that the different distribution of Ras isoforms and the ability of cells to alternatively process these proteins may explain in part the resistance of some cell lines to FPT inhibitors.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Preclinical excitement with farnesyltransferase inhibitors did not translate to clinical utility with multiple negative phase II and phase III studies, likely due to presence of bypass prenylation pathway by geranylgeranylation.
“However, preclinical excitement did not transcribe to clinical utility with multiple negative phase II and phase III studies, likely due to presence of bypass prenylation pathway by geranylgeranylation [79].”
From Drugging KRAS: Current perspectives and state-of-art review (2022) · cites this paper as [79]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061 · see citing works
Barbacid, M. (1987) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.56.070187.004023 · Cited by 3,885 · see citing works
PROTEIN PRENYLATION: Molecular Mechanisms and Functional Consequences
Zhang, F. L., & Casey, P. J. (1996) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.65.070196.001325 · Cited by 2,018 · see citing works
Self-citationAll ras proteins are polyisoprenylated but only some are palmitoylated
Hancock, J. F., Magee, A. I., Childs, J. E., & Marshall, C. J. (1989) · Cell · doi:10.1016/0092-8674(89)90054-8 · Cited by 1,775 · see citing works
FUNCTION AND REGULATION OF RAS
Lowy, D. R., & Willumsen, B. M. (1993) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.62.070193.004223 · Cited by 1,164 · see citing works
Hancock, J. F., Paterson, H., & Marshall, C. J. (1990) · Cell · doi:10.1016/0092-8674(90)90294-o · Cited by 1,042 · see citing works
PROTEIN ISOPRENYLATION AND METHYLATION AT CARBOXYL-TERMINAL CYSTEINE RESIDUES
Clarke, S. G. (1992) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.61.070192.002035 · Cited by 895 · see citing works
p21ras is modified by a farnesyl isoprenoid.
Casey, P. J., Solski, P. A., Der, C. J., & Buss, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8323 · Cited by 856 · see citing works
Inhibition of purified p21 farnesyl:protein transferase by Cys-AAX tetrapeptides
Reiss, Y., Goldstein, J. L., Seabra, M. C., Casey, P. J., & Brown, M. S. (1990) · Cell · doi:10.1016/0092-8674(90)90242-7 · Cited by 815 · see citing works
Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal Cells
James, G. L., Goldstein, J. L., Brown, M. S., Rawson, T. E., Somers, T. C., McDowell, R. S., Crowley, C. W., Lucas, B. K., Levinson, A. D., & Marsters, J. C. (1993) · Science · doi:10.1126/science.8316834 · Cited by 630 · see citing works
Selective Inhibition of ras -Dependent Transformation by a Farnesyltransferase Inhibitor
Kohl, N. E., Mosser, S. D., DeSolms, S. J., Giuliani, E. A., Pompliano, D. L., Graham, S. L., Smith, R. L., Scolnick, E. M., Oliff, A. I., & Gibbs, W. W. (1993) · Science · doi:10.1126/science.8316833 · Cited by 579 · see citing works
Kohl, N. E., Omer, C. A., Conner, M. W., Anthony, N. J., Davide, J. P., DeSolms, S. J., Giuliani, E. A., Gomez, R. P., Graham, S. L., Hamilton, K., et al. (1995) · Nature Medicine · doi:10.1038/nm0895-792 · Cited by 540 · see citing works
Kato, K., Cox, A. D., Hisaka, M. M., Graham, S. M., Buss, J. E., & Der, C. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.14.6403 · Cited by 537 · see citing works
Genetic and Pharmacological Suppression of Oncogenic Mutations in RAS Genes of Yeast and Humans
Schafer, W. R., Kim, R., Sterne, R. E., Thorner, J. W., Kim, S., & Rine, J. (1989) · Science · doi:10.1126/science.2569235 · Cited by 530 · see citing works
Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic
Gibbs, J. B., Oliff, A. I., & Kohl, N. E. (1994) · Cell · doi:10.1016/0092-8674(94)90308-5 · Cited by 517 · see citing works
Sepp‐Lorenzino, L., Ma, Z., Rands, E., Kohl, N. E., Gibbs, W. W., Oliff, A. I., & Rosen, N. X. (1995) · PubMed · Cited by 383 · see citing works
Sequence requirement for peptide recognition by rat brain p21ras protein farnesyltransferase.
Reiss, Y., Stradley, S. J., Gierasch, L. M., Brown, M. S., & Goldstein, J. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.3.732 · Cited by 312 · see citing works
James, G. L., Goldstein, J. L., & Brown, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6221 · Cited by 290 · see citing works
Protein farnesyltransferase inhibitors block the growth of ras-dependent tumors in nude mice.
Kohl, N. E., Wilson, F. R., Mosser, S. D., Giuliani, E. A., DeSolms, S. J., Conner, M. W., Anthony, N. J., Holtz, W. J., Gomez, R. P., & Lee, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.9141 · Cited by 285 · see citing works
Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Gibbs, W. W., Pompliano, D. L., Mosser, S. D., Rands, E., Lingham, R. B., Singh, S. B., Scolnick, E. M., Kohl, N. E., & Oliff, A. I. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52998-7 · Cited by 259 · see citing works
Steady-state kinetic mechanism of ras farnesyl:protein transferase
Pompliano, D. L., Rands, E., Schaber, M. D., Mosser, S. D., Anthony, N. J., & Gibbs, W. W. (1992) · Biochemistry · doi:10.1021/bi00130a010 · Cited by 246 · see citing works
Nagasu, T., Yoshimatsu, K., Rowell, C., Lewis, M. D., & Garcia, A. M. (1995) · PubMed · Cited by 238 · see citing works
Yokoyama, K., Goodwin, G. W., Ghomashchi, F., Glomset, J. A., & Gelb, M. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.12.5302 · Cited by 224 · see citing works
Peptidomimetic inhibitors of Ras farnesylation and function in whole cells.
Garcia, A. M., Rowell, C. A., Ackermann, K. E., Kowalczyk, J. J., & Lewis, M. D. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)46638-5 · Cited by 220 · see citing works
Regulated Transcription of c-Ki- ras and c- myc During Compensatory Growth of Rat Liver
Goyette, M., Petropoulos, C. J., Shank, P. R., & Fausto, N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.8.1493 · Cited by 201 · see citing works
[40] Biological assays for Ras transformation
Clark, G. J., Cox, A. D., Graham, S. M., & Der, C. J. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(95)55042-9 · Cited by 198 · see citing works
Enzymatic modification of proteins with a geranylgeranyl isoprenoid.
Casey, P. J., Thissen, J., & Moomaw, J. F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.19.8631 · Cited by 176 · see citing works
CAAX Geranylgeranyl Transferase Transfers Farnesyl as Efficiently as Geranylgeranyl to RhoB
Armstrong, S. A., Hannah, V. C., Goldstein, J. L., & Brown, M. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.7864 · Cited by 165 · see citing works
Mammalian protein geranylgeranyltransferase. Subunit composition and metal requirements.
Moomaw, J. F., & Casey, P. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41945-x · Cited by 159 · see citing works
Novel Tricyclic Inhibitors of Farnesyl Protein Transferase
Bishop, W. R., Bond, R. W., Petrin, J., Wang, L., Patton, R., Doll, R. J., Njoroge, G. F., Catino, J. J., Schwartz, J. L., Windsor, W. T., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30611 · Cited by 153 · see citing works
Self-citationOmer, C. A., Kral, A. M., Diehl, R. E., Prendergast, G. C., Powers, S., Allen, C. M., Gibbs, W. W., & Kohl, N. E. (1993) · Biochemistry · doi:10.1021/bi00070a028 · Cited by 137 · see citing works
Manne, V., Yan, N., Jm, C., Av, T., Ricca, C. S., Brown, J. G., Andahazy, M., Schmidt, R. J., Patel, D. V., & Zahler, R. (1995) · PubMed · Cited by 131 · see citing works
Nigam, M., Seong, C. M., Qian, Y., Hamilton, A. D., & Sebti, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36832-2 · Cited by 114 · see citing works
cDNA cloning and expression of rat and human protein geranylgeranyltransferase type-I.
Zhang, F. L., Diehl, R. E., Kohl, N. E., Gibbs, W. W., Bruno Giros, A., Casey, P. J., & Omer, C. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41845-x · Cited by 96 · see citing works
Self-citationPompliano, D. L., Schaber, M. D., Mosser, S. D., Omer, C. A., Shafer, J. A., & Gibbs, W. W. (1993) · Biochemistry · doi:10.1021/bi00083a038 · Cited by 96 · see citing works
Chen, W. J., Moomaw, J. F., Overton, L. K., Kost, T. A., & Casey, P. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98402-4 · Cited by 95 · see citing works
Properties and kinetic mechanism of recombinant mammalian protein geranylgeranyltransferase type I.
Zhang, F. L., Moomaw, J. F., & Casey, P. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31539-9 · Cited by 64 · see citing works
Self-citationRegions Outside of the CAAX Motif Influence the Specificity of Prenylation of G Protein γ Subunits
Kalman, V. K., Erdman, R., Maltese, W. A., & Robishaw, J. D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14835 · Cited by 40 · see citing works
Substitution of Cadmium for Zinc in Farnesyl:Protein Transferase Alters Its Substrate Specificity
Zhang, F. L., Fu, H., Casey, P. J., & Bishop, W. R. (1996) · Biochemistry · doi:10.1021/bi960574+ · Cited by 39 · see citing works
Self-citation[1] Refolding and purification of ras proteins
Campbell, S. L., & Carpenter, J. W. (1995) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(95)55003-8 · Cited by 34 · see citing works
Cox, A. D., Graham, S. M., Solski, P. A., Buss, J. E., & Der, C. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50235-6 · Cited by 18 · see citing works
Flagged first, then by citations
Research works printed but not linked: 41
- [1]1. Barbacid, M. Annu. Rev. Biochem. 1987; 56:779-827 Google Scholar
- [2]2. Lowy, D.R. ∙ Willumsen, B.M. Annu. Rev. Biochem. 1993; 62:851-891 Scopus (1166) Google Scholar
- [3]3. Bos, J.L. Cancer Res. 1989; 49:4682-4689 Google Scholar
- [4]4. Clark, G.J. ∙ Cox, A.D. ∙ Graham, S.M. ... Methods Enzymol. 1995; 255:395-411 Google Scholar
- [5]5. Leon, J. ∙ Guerrero, I. ∙ Pellicer, A. Mol. Cell. Biol. 1987; 4:1493-1498 Google Scholar
- [6]6. Casey, P.J. ∙ Solski, P.A. ∙ Der, C.J. ... Proc. Natl. Acad. Sci. U. S. A. 1989; 86:8323-8327 Google Scholar
- [7]7. Hancock, J.F. ∙ Magee, A.I. ∙ Childs, J.E. ... Cell. 1989; 57:1167-1177 Google Scholar
- [8]8. Schafer, W.R. ∙ Kim, R. ∙ Sterne, R. ... Science. 1989; 245:379-385 Google Scholar
- [9]9. Reiss, Y. ∙ Goldstein, J.L. ∙ Seabra, M.C. ... Cell. 1990; 62:81-88 Google Scholar
- [10]10. Clarke, S. Annu. Rev. Biochem. 1992; 61:355-386 Google Scholar
- [11]11. Zhang, F.L. ∙ Casey, P.J. Annu. Rev. Biochem. 1996; 65:241-269 Google Scholar
- [12]12. Reiss, Y. ∙ Stradley, S.J. ∙ Gierasch, L.M. ... Proc. Natl. Acad. Sci. U. S. A. 1991; 88:732-736 Google Scholar
- [13]13. Casey, P.J. ∙ Thissen, J.A. ∙ Moomaw, J.F. Proc. Natl. Acad. Sci. U. S. A. 1991; 88:8631-8635 Google Scholar
- [14]14. Yokoyama, K. ∙ Goodwin, G.W. ∙ Ghomashchi, F. ... Proc. Natl. Acad. Sci. U. S. A. 1991; 88:5302-5306 Google Scholar
- [15]15. James, G.L. ∙ Goldstein, J.L. ∙ Brown, M.S. J. Biol. Chem. 1995; 270:6221-6226 Google Scholar
- [16]16. Armstrong, S.A. ∙ Hannah, V.C ∙ Goldstein, J.L. ... J. Biol. Chem. 1995; 270:7864-7868 Google Scholar
- [17]17. Hancock, J.F. ∙ Paterson, H. ∙ Marshall, C.J. Cell. 1990; 63:133-139 Google Scholar
- [18]18. Kato, K. ∙ Cox, A.D. ∙ Hisaka, M.M. ... Proc. Natl. Acad. Sci. U. S. A. 1992; 89:6403-6407 Google Scholar
- [19]19. Gibbs, J.B. ∙ Oliff, A. ∙ Kohl, N.E. Cell. 1994; 77:175-178 Google Scholar
- [20]20. Gibbs, J.B. ∙ Pompliano, D.L. ∙ Mosser, S.D. ... J. Biol. Chem. 1993; 268:7617-7620 Google Scholar
- [21]21. James, G.L. ∙ Goldstein, J.L. ∙ Brown, M.S. ... Science. 1993; 260:1937-1942 Google Scholar
- [22]22. Kohl, N.E. ∙ Mosser, S.D. ∙ deSolms, S.J. ... Science. 1993; 260:1934-1937 Google Scholar
- [23]23. Garcia, A.M. ∙ Rowell, C. ∙ Ackermann, K. ... J. Biol. Chem. 1993; 268:18415-18418 Google Scholar
- [24]24. Nigam, M. ∙ Seong, C-M. ∙ Qian, Y. ... J. Biol. Chem. 1993; 268:20695-20698 Google Scholar
- [25]25. Manne, V. ∙ Yan, N. ∙ Carboni, J.M. ... Oncogene. 1995; 10:1763-1779 Google Scholar
- [26]26. Bishop, W.R. ∙ Bond, R. ∙ Petrin, J. ... J. Biol. Chem. 1995; 270:30611-30618 Google Scholar
- [27]27. Kohl, N.E. ∙ Wilson, F.R. ∙ Mosser, S.D. ... Proc. Natl. Acad. Sci. U. S. A. 1994; 91:9141-9145 Google Scholar
- [28]28. Kohl, N.E. ∙ Omer, C.A. ∙ Conner, M.W. ... Nat. Med. 1995; 1:792-797 Google Scholar
- [29]29. Sepp-Lorenzino, L. ∙ Ma, Z. ∙ Rands, E. ... Cancer Res. 1995; 55:5302-5309 Google Scholar
- [30]30. Nagasu, T. ∙ Yoshimatsu, K. ∙ Rowell, C. ... Cancer Res. 1995; 55:5310-5314 Google Scholar
- [31]31. Chen, W-J. ∙ Moomaw, J.F. ∙ Overton, L. ... J. Biol. Chem. 1993; 268:9675-9680 Google Scholar
- [32]32. Campbell-Burk, S.L. ∙ Carpenter, J.W. Methods Enzymol. 1995; 255:3-12 Google Scholar
- [33]33. Zhang, F.L. ∙ Diehl, R.E. ∙ Kohl, N.E. ... J. Biol. Chem. 1994; 269:3175-3180 Google Scholar
- [35]35. Zhang, F.L. ∙ Moomaw, J.F. ∙ Casey, P.J. J. Biol. Chem. 1994; 269:23465-23470 Google Scholar
- [36]36. Zhang, F.L. ∙ Fu, H.-W. ∙ Casey, P.J. ... Biochemistry. 1996; 35:8166-8171 Google Scholar
- [37]37. Moomaw, J.F. ∙ Casey, P.J. J. Biol. Chem. 1992; 267:17438-17443 Google Scholar
- [38]38. Pompliano, D.L. ∙ Schaber, M.D. ∙ Mosser, S.D. ... Biochemistry. 1993; 32:8341-8347 Google Scholar
- [39]39. Pompliano, D.L. ∙ Rands, E. ∙ Schaber, M.D. ... Biochemistry. 1992; 31:3800-3807 Google Scholar
- [40]40. Omer, C.A. ∙ Kral, A.M. ∙ Diehl, R.E. ... Biochemistry. 1993; 32:5167-5176 Google Scholar
- [41]41. Kalman, V.K. ∙ Erdman, R.A. ∙ Maltese, W.A. ... J. Biol. Chem. 1995; 270:14835-14841 Google Scholar
- [42]42. Cox, A.D. ∙ Graham, S.M. ∙ Solski, P.A. ... J. Biol. Chem. 1993; 268:11548-11552 Google Scholar Figures (6) Article metrics Related Articles Advertisement Hide CaptionDownloadSee figure in Article Toggle Thumbstrip Fig. 1 Fig. 2 Fig. 3 Fig. 4 Fig. 5 Fig. 6 Download .PPT Home Access for Developing Countries Articles Papers in Press Current Volume Archive Editorials ASBMB Award Articles JBC Reviews Meeting Reports Thematic Series Virtual Issues Classics Reflections Editors' Picks JBC Communications eLetters Tabor Awards For Authors Information for Authors About Open Access Permissions Submit manuscript Submission Help Contact Us Contact Information Journal Info About the Journal Early Career Reviewers Editorial Board Image Gallery New Content Alerts All Topics Bioenergetics Cell Biology Computational Biology Developmental Biology DNA and Chromosomes Enzymology Gene Regulation Genomics and Proteomics Glycobiology and Extracellular Matrices Immunology Lipids Membrane Biology Metabolism
Cited by
Sorted by citations
Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies
Jiang, H., Zhang, X., Chen, X., Aramsangtienchai, P., Tong, Z., & Lin, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00750 · Cited by 501 · see citing works
Capell, B. C., Erdos, M. R., Madigan, J. P., Fiordalisi, J. J., Varga, R., Conneely, K. N., Gordon, L. B., Der, C. J., Cox, A. D., & Collins, F. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506001102 · Cited by 395 · see citing works
Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification
Roberts, P. J., Mitin, N., Keller, P. J., Chenette, E. J., Madigan, J. P., Currin, R. O., Cox, A. D., Wilson, O., Kirschmeier, P., & Der, C. J. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800882200 · Cited by 362 · see citing works
Self-citationAshar, H. R., James, L. J., Gray, K., Carr, D. M., Black, S., Armstrong, L., Bishop, W. R., & Kirschmeier, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003469200 · Cited by 321 · see citing works
Self-citationReuter, C. W., Morgan, M. A., & Bergmann, L. (2000) · Blood · doi:10.1182/blood.v96.5.1655 · Cited by 300 · see citing works
Thematic review series: Lipid Posttranslational Modifications. Farnesyl transferase inhibitors
Basso, A. D., Kirschmeier, P. T., & Bishop, W. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.r500012-jlr200 · Cited by 297 · see citing works
Self-citationReid, T. S., Terry, K. L., Casey, P. J., & Beese, L. S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.08.056 · Cited by 264 · see citing works
Lobell, R. B., Omer, C. A., Abrams, M. T., Bhimnathwala, H., Brucker, M. J., Buser, C. A., Davide, J. P., DeSolms, S. J., Dinsmore, C. J., Ellis-Hutchings, M., et al. (2001) · PubMed · Cited by 239 · see citing works
Adjei, A. A., Mauer, A., Bruzek, L., Marks, R. S., Hillman, S., Geyer, S., Hanson, L. J., Wright, J. J., Erlichman, C., Kaufmann, S. H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.09.075 · Cited by 219 · see citing works
Ras and Rap1: A tale of two GTPases
Shah, S. K., Brock, E. J., Ji, K., & Mattingly, R. R. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.03.005 · Cited by 210 · see citing works
Ras—A Molecular Switch Involved in Tumor Formation
Wittinghofer, A., & Waldmann, H. (2000) · Angewandte Chemie International Edition · doi:10.1002/1521-3773(20001201)39:23 · Cited by 187 · see citing works
Statins Reduce Amyloid-β Production through Inhibition of Protein Isoprenylation
Ostrowski, S. M., Wilkinson, B. L., Golde, T. E., & Landreth, G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702640200 · Cited by 180 · see citing works
Farnesylated lamins, progeroid syndromes and farnesyl transferase inhibitors
Rusiñol, A. E., & Sinensky, M. S. (2006) · Journal of Cell Science · doi:10.1242/jcs.03156 · Cited by 173 · see citing works
Analysis of the genome to personalize therapy for melanoma
Davies, M. A., & Samuels, Y. (2010) · Oncogene · doi:10.1038/onc.2010.323 · Cited by 167 · see citing works
Drugging KRAS: Current perspectives and state-of-art review
Parikh, K., Banna, G., Liu, S. V., Friedlaender, A., Desai, A., Subbiah, V., & Addeo, A. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01375-4 · Cited by 164 · see citing works
Cloning and Characterization of a Mammalian Prenyl Protein-specific Protease
Otto, J. C., Kim, E. J.-H., Young, S. G., & Casey, P. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8379 · Cited by 164 · see citing works
Basso, A. D., Mirza, A., Liu, G., Long, B. J., Bishop, W. R., & Kirschmeier, P. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503763200 · Cited by 162 · see citing works
Self-citationBrunner, T. B., Hahn, S. M., Gupta, A., Muschel, R. J., McKenna, W. G., & Bernhard, E. J. (2003) · PubMed · Cited by 147 · see citing works
RETRACTED: Downstream effectors of oncogenic ras in multiple myeloma cells
Hu, L., Shi, Y., Hsu, J.-H., Gera, J., Ness, B. V., & Lichtenstein, A. K. (2003) · Blood · doi:10.1182/blood-2002-08-2640 · Cited by 142 · see citing works
RetractedFarnesyltransferase inhibitors: promises and realities
Cox, A. D. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00181-9 · Cited by 141 · see citing works
Ras Proteins: Recent Advances and New Functions
Rebollo, A., & Martínez‐A, C. (1999) · Blood · doi:10.1182/blood.v94.9.2971 · Cited by 140 · see citing works
Crul, M., de Klerk, G. J., Swart, M., Veer, L. J. V., de Jong, D., Boerrigter, L., Palmer, P. A., Bol, C. J., Tan, H., GAST, G. C. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.116 · Cited by 131 · see citing works
Dasgupta, B., Yi, Y., Hegedűs, B., Weber, J. D., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1842 · Cited by 128 · see citing works
Lobell, R. B., Liu, D., Buser, C. A., Davide, J. P., DePuy, E., Hamilton, K., Koblan, K. S., Lee, Y., Mosser, S. D., Motzel, S. L., et al. (2002) · PubMed · Cited by 121 · see citing works
Sepp‐Lorenzino, L., & Rosen, N. X. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20243 · Cited by 117 · see citing works
Long, S. B., Casey, P. J., & Beese, L. S. (2000) · Structure · doi:10.1016/s0969-2126(00)00096-4 · Cited by 114 · see citing works
Feldkamp, M. M., Lau, N. C., & Guha, A. (1999) · Oncogene · doi:10.1038/sj.onc.1203105 · Cited by 114 · see citing works
Ashar, H. R., James, L. J., Gray, K., Carr, D. M., McGuirk, M., Maxwell, E., Black, S., Armstrong, L., Doll, R. J., Taveras, A. G., et al. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5076 · Cited by 109 · see citing works
Self-citationOmer, C. A., Chen, Z., Diehl, R. E., Conner, M. W., Chen, H. Y., Trumbauer, M. E., Gopal-Truter, S., Seeburger, G., Bhimnathwala, H., Abrams, M. T., et al. (2000) · PubMed · Cited by 105 · see citing works
Kang, S. S., Palau, V. E., Lightner, J., Chakraborty, K., Stone, W. L., Campbell, S., Reddy, S. A. G., & Krishnan, K. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.008 · Cited by 100 · see citing works
Glioma Formation in Neurofibromatosis 1 Reflects Preferential Activation of K-RAS in Astrocytes
Dasgupta, B., Li, W., Perry, A., & Gutmann, D. H. (2005) · Cancer Research · doi:10.1158/0008-5472.236.65.1 · Cited by 98 · see citing works
Farnesyltransferase inhibitors: targeting the molecular basis of cancer
Oliff, A. I. (1999) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00007-4 · Cited by 97 · see citing works
Feldkamp, M. M., Lau, N. C., Roncari, L., & Guha, A. (2001) · PubMed · Cited by 92 · see citing works
Farnesyltransferase inhibitors versus Ras inhibitors
Gibbs, W. W., Graham, S. L., Hartman, G. D., Koblan, K. S., Kohl, N. E., Omer, C. A., & Oliff, A. I. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80010-5 · Cited by 91 · see citing works
Fiordalisi, J. J., Johnson, R. L., Weinbaum, C., Sakabe, K., Chen, Z., Casey, P. J., & Cox, A. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305733200 · Cited by 90 · see citing works
The Small GTP-Binding Protein Rho Potentiates AP-1 Transcription in T Cells
Chang, J., Pratt, J. C., Sawasdikosol, S., Kapeller, R., & Burakoff, S. J. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.9.4986 · Cited by 87 · see citing works
Ras biochemistry and farnesyl transferase inhibitors: a literature survey
Crul, M., de Klerk, G. J., Beijnen, J. H., & Schellens, J. H. M. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200103000-00001 · Cited by 87 · see citing works
Prendergast, G. C., & Oliff, A. I. (2000) · Seminars in Cancer Biology · doi:10.1006/scbi.2000.0335 · Cited by 82 · see citing works
Farnesyltransferase inhibitors: mechanism and applications
Rane, N. S., & Prendergast, G. C. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.12.2105 · Cited by 78 · see citing works
Recent Advances in Therapeutic Strategies to Improve Colorectal Cancer Treatment
Gmeiner, W. H. (2024) · Cancers · doi:10.3390/cancers16051029 · Cited by 78 · see citing works
The Ras‐ERK pathway: Understanding site‐specific signaling provides hope of new anti‐tumor therapies
Calvo, F., Agudo‐Ibáñez, L., & Crespo, P. (2010) · BioEssays · doi:10.1002/bies.200900155 · Cited by 75 · see citing works
Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid
Elad, G., Paz, A., Haklai, R., Marciano, D., Cox, A. D., & Kloog, Y. (1999) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(99)00144-5 · Cited by 77 · see citing works
Gana‐Weisz, M., Halaschek-Wiener, J., Jansen, B., Elad, G., Haklai, R., & Kloog, Y. (2002) · PubMed · Cited by 72 · see citing works
Rebollo, A., Pérez‐Sala, D., & Martínez‐A, C. (1999) · Oncogene · doi:10.1038/sj.onc.1202875 · Cited by 71 · see citing works
Carloni, V., Pinzani, M., Giusti, S., Romanelli, R. G., Parola, M., Bellomo, G., Failli, P., Hamilton, A. D., Sebti, S. M., Laffi, G., et al. (2000) · Hepatology · doi:10.1002/hep.510310121 · Cited by 66 · see citing works
Ras – ein molekularer Schalter bei der Tumorentstehung
Wittinghofer, A., & Waldmann, H. (2000) · Angewandte Chemie · doi:10.1002/1521-3757(20001201)112:23 · Cited by 66 · see citing works
Farnesylated proteins and cell cycle progression
Tamanoi, F., Kato‐Stankiewicz, J., Chen, J., Machado, I. M. P., & Thapar, N. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10067 · Cited by 65 · see citing works
K-Ras prenylation as a potential anticancer target
Baranyi, M., Buday, L., & Hegedűs, B. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09902-w · Cited by 62 · see citing works
Dai, Y., Rahmani, M., Pei, X., Khanna, P., Han, S. I., Mitchell, C., Dent, P., & Grant, S. (2004) · Blood · doi:10.1182/blood-2004-07-2767 · Cited by 61 · see citing works
Wang, C., Liao, Y., Mischel, P. S., Iwamoto, K. S., Cacalano, N. A., & McBride, W. H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0185 · Cited by 60 · see citing works
Shen, M., Pan, P., Li, Y., Li, D., Yu, H., & Hou, T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.10.002 · Cited by 54 · see citing works
Onono, F. O., Morgan, M. A., Spielmann, H. P., Andres, D., Subramanian, T., Ganser, A., & Reuter, C. W. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m900597-mcp200 · Cited by 54 · see citing works
Therapeutic intervention and signaling
Heimbrook, D. C., & Oliff, A. I. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80152-x · Cited by 54 · see citing works
40 Years of RAS—A Historic Overview
Fernández‐Medarde, A., Rivas, J. D. L., & Santos, E. (2021) · Genes · doi:10.3390/genes12050681 · Cited by 53 · see citing works
Zwolak, P., Manivel, J. C., Jasiński, P., Kirstein, M. N., Dudek, A. Z., Fisher, J. E., & Cheng, E. Y. (2010) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.h.01679 · Cited by 51 · see citing works
Chemical Biology of Lipidated Proteins
Triola, G., Waldmann, H., & Hedberg, C. (2011) · ACS Chemical Biology · doi:10.1021/cb200460u · Cited by 50 · see citing works
R115777 induces Ras-independent apoptosis of myeloma cells via multiple intrinsic pathways
Beaupre, D. M., Cepero, E., Obeng, E. A., Boise, L., & Lichtenheld, M. G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.179.3.2 · Cited by 49 · see citing works
Prenylation of Rab8 GTPase by type I and type II geranylgeranyl transferases
WILSON, A. L., Erdman, R., Castellano, F., & Maltese, W. A. (1998) · Biochemical Journal · doi:10.1042/bj3330497 · Cited by 49 · see citing works
Lantry, L. E. (2000) · Carcinogenesis · doi:10.1093/carcin/21.1.113 · Cited by 47 · see citing works
Chen, X., Makarewicz, J., Knauf, J. A., Johnson, L. K., & Fagin, J. A. (2013) · Oncogene · doi:10.1038/onc.2013.489 · Cited by 46 · see citing works
Tsimberidou, A. M., Rudek, M. A., Hong, D. S., Ng, C. S., Blair, J., Goldsweig, H. G., & Kurzrock, R. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1027-4 · Cited by 46 · see citing works
Implications of farnesyltransferase and its inhibitors as a promising strategy for cancer therapy
Klochkov, S. G., Евгеньевна, Н. М., Yarla, N. S., Parvathaneni, M., Sharma, B., Tarasov, V. V., Barreto, G. E., Бачурин, С. О., Ashraf, G. M., & Aliev, G. M. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.010 · Cited by 46 · see citing works
Russo, P., Malacarne, D., Falugi, C., Trombino, S., & O'Connor, P. M. (2002) · International Journal of Cancer · doi:10.1002/ijc.10461 · Cited by 44 · see citing works
Suzuki, T., Ito, M., Ezure, T., Shikata, M., Ando, E., Utsumi, T., Tsunasawa, S., & Nishimura, O. (2007) · PROTEOMICS · doi:10.1002/pmic.200700237 · Cited by 44 · see citing works
Inhibition of RAS-targeted prenylation: protein farnesyl transferase inhibitors revisited
Hill, B. T., Perrin, D., & Kruczynski, A. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00053-0 · Cited by 44 · see citing works
Hosokawa, A., Wollack, J. W., Zhang, Z., Chen, L., Bárány, G., & Distefano, M. D. (2007) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-007-9090-3 · Cited by 43 · see citing works
González‐Pérez, V., Reiner, D. J., Alan, J. K., Mitchell, C. E., Edwards, L. J., Khazak, V., Der, C. J., & Cox, A. D. (2010) · Journal of Molecular Signaling · doi:10.1186/1750-2187-5-2 · Cited by 42 · see citing works
How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization
Brock, E. J., Ji, K., Reiners, J. J., & Mattingly, R. R. (2015) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557515666151001154002 · Cited by 41 · see citing works
Novotny, C. J., Hamilton, G. L., McCormick, F. P., & Shokat, K. M. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00374 · Cited by 41 · see citing works
Stickney, J. T., & Buss, J. E. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.7.2191 · Cited by 41 · see citing works
Farnesyltransferase inhibitors: where are we now?
Tsimberidou, A. M., Chandhasin, C., & Kurzrock, R. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.535516 · Cited by 39 · see citing works
Morgan, M. A., Wegner, J., Aydilek, E., Ganser, A., & Reuter, C. W. (2003) · Leukemia · doi:10.1038/sj.leu.2403022 · Cited by 39 · see citing works
Roskoski, R. J., & Ritchie, P. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0768 · Cited by 38 · see citing works
Yonemoto, M., Satoh, T., Arakawa, H., Suzuki‐Takahashi, I., Monden, Y., Kodera, T., Tanaka, K., Aoyama, T., Iwasawa, Y., Kamei, T., et al. (1998) · Molecular Pharmacology · doi:10.1124/mol.54.1.1 · Cited by 37 · see citing works
Nielsen, L. L., Shi, B., Hajian, G., Yaremko, B., Lipari, P., Ferrari, E., Gurnani, M., Malkowski, M. G., Chen, J., Bishop, W. R., et al. (1999) · PubMed · Cited by 36 · see citing works
Self-citationTang, R., Shuldiner, E. G., Kelly, M. R., Murray, C. W., Hebert, J. D., Andrejka, L., Tsai, M. K., Hughes, N. W., Parker, M. I., Cai, H., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-022-01049-w · Cited by 37 · see citing works
Badar, T., Cortes, J. E., Ravandi, F., O'Brien, S. M., Verstovšek, S., Garcia‐Manero, G., Kantarjian, H. M., & Borthakur, G. M. (2015) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2015.02.018 · Cited by 35 · see citing works
Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia
Morgan, M. A., Ganser, A., & Reuter, C. W. (2003) · Leukemia · doi:10.1038/sj.leu.2403024 · Cited by 35 · see citing works
Farnesyltransferase inhibitors and their potential in the treatment of breast carcinoma
Bono, J. S. D. (2003) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.08.010 · Cited by 35 · see citing works
Dorrell, C., Takenaka, K., Minden, M. D., Hawley, R. G., & Dick, J. E. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.6993-7002.2004 · Cited by 34 · see citing works
Pre-clinical development of farnesyltransferase inhibitors
Lobell, R. B., & Kohl, N. E. (1998) · Cancer and Metastasis Reviews · doi:10.1023/a:1006018922878 · Cited by 34 · see citing works
Targeting KRAS in Colorectal Cancer: A Bench to Bedside Review
Bteich, F., Mohammadi, M., Li, T., Bhat, M. A., Sofianidi, A. A., Wei, N., & Kuang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512030 · Cited by 32 · see citing works
Pei, X., Dai, Y., Rahmani, M., Li, W., Dent, P., & Grant, S. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2346 · Cited by 33 · see citing works
CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents
Omer, C. A. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01129-2 · Cited by 33 · see citing works
Mattingly, R. R. (2013) · ISRN Oncology · doi:10.1155/2013/536529 · Cited by 32 · see citing works
Rao, K. N., Zhang, W., Li, L., Anand, M., & Khanna, H. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw281 · Cited by 32 · see citing works
Knight, L. A., Kurbacher, C. M., Glaysher, S., Fernando, A., Reichelt, R., Dexel, S., Reinhold, U., & Cree, I. A. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-38 · Cited by 30 · see citing works
Chemistry and Biology of Moverastins, Inhibitors of Cancer Cell Migration, Produced by Aspergillus
Takemoto, Y., Watanabe, H., Uchida, K., Matsumura, K., Nakae, K., Tashiro, E., Shindo, K., Kitahara, T., & Imoto, M. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.09.017 · Cited by 30 · see citing works
Brassard, D., English, J. M., Malkowski, M. G., Kirschmeier, P. T., Nagabhushan, T. L., & Bishop, W. R. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5440 · Cited by 30 · see citing works
Self-citationBuser, C. A., Dinsmore, C. J., Fernandes, C., Greenberg, I. B., Hamilton, K., Mosser, S. D., Walsh, E. S., Williams, T. M., & Koblan, K. S. (2001) · Analytical Biochemistry · doi:10.1006/abio.2000.4972 · Cited by 29 · see citing works
Biology, pathology, and therapeutic targeting of RAS
Rhett, J. M., Khan, I., & O’Bryan, J. P. (2020) · Advances in cancer research · doi:10.1016/bs.acr.2020.05.002 · Cited by 28 · see citing works
Novel therapeutic targets in squamous cell carcinoma of the head and neck
Cohen, E. E. W. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.09.010 · Cited by 27 · see citing works
Proteomic Analysis of Bovine Brain G Protein γ Subunit Processing Heterogeneity
Cook, L. A., Schey, K. L., Wilcox, M. D., Dingus, J., Ettling, R., Nelson, T., Knapp, D. R., & Hildebrandt, J. D. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m500223-mcp200 · Cited by 27 · see citing works
Evidence of a Role for Ki-RAS in the Stimulated Proliferation of Renal Fibroblasts
Sharpe, C. C., Dockrell, M. E. C., Scott, R. P., Noor, M., Cowsert, L. M., Monia, B. P., & Hendry, B. M. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061186 · Cited by 27 · see citing works
Targeted Therapy for Melanoma: A Primer
Davies, M. A., & Gershenwald, J. E. (2010) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2010.09.003 · Cited by 26 · see citing works
Petit, T., Izbicka, E., Lawrence, R. A., Bishop, W. R., Weitman, S. D., & Hoff, D. D. V. (1999) · Annals of Oncology · doi:10.1023/a:1008313232381 · Cited by 26 · see citing works
Self-citationThaler, R., Spitzer, S., Karlic, H., Berger, C., Klaushofer, K., & Varga, F. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.016 · Cited by 24 · see citing works
Working together: Farnesyl transferase inhibitors and statins block protein prenylation
Wojtkowiak, J. W. (2009) · Molecular and Cellular Pharmacology · doi:10.4255/mcpharmacol.09.01 · Cited by 24 · see citing works
Caraglia, M. (2005) · Frontiers in bioscience · doi:10.2741/1720 · Cited by 24 · see citing works
- Authors
- Zhang, F. L., Kirschmeier, P., Carr, D., James, L., Bond, R. W., Wang, L., Patton, R., Windsor, W. T., Syto, R., Zhang, R., & Bishop, W. R.
- Corresponding author
- Bishop, W. Robert
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-04
- Volume
- 272
- Issue
- 15
- Pages
- 10232-10239
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2156654096
- Cited by
- 197
- References
- 41
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 6 · 2022: 2 · 2021: 6 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 4 · 2014: 2 · 2013: 4 · 2012: 7
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Plant biochemistry and biosynthesis
- Keywords
- Ras isoforms, Ha-ras, NRAS, farnesyltransferase, protein prenylation, geranylgeranylation, CAAX motif, substrate affinity, carboxyl-terminal peptide, polylysine, oncogenic Ras, cell transformation
- MeSH terms
- Benzazepines, Binding Sites, Enzyme Inhibitors, Humans, Kinetics, Methionine, Piperidines, Polylysine, Transferases, Protein Prenylation, ras Proteins, Alkyl and Aryl Transferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review